Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FQGXD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 MG/2.4 ML on-body injector units. This firm fixed-price delivery order, awarded on July 16, 2025, with an ultimate completion date of August 6, 2025, represents a pediatric or specialty pharmaceutical delivery under the agency's medical supply chain operations. The contract utilizes no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's established capability to support federal medical procurement requirements. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. SKYRIZI, a biologics treatment typically used for dermatological and immunological conditions, demonstrates the breadth of specialty medications delivered through this arrangement to support Defense Health Agency and other federal healthcare system requirements. The delivery order structure and firm fixed pricing reflect standard DLA procurement practices for medical commodities supporting military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQGXD?
SPE2DB25FQGXD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 16, 2025.
How much is contract SPE2DB25FQGXD worth?
The government has obligated $11,830 on SPE2DB25FQGXD.
Is contract SPE2DB25FQGXD an order under another contract?
Yes. SPE2DB25FQGXD is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQGXD competed?
The extent of competition for SPE2DB25FQGXD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award